Comparison of fluorescence in situ hybridization -FISH- and conventional cytology for early detection of urothelial carcinoma

Nadina Erill1, Anna Colomer1, Míriam Gorriz2, Naim Hannaoui3, Ruth Román1, Maria Conangla2, Josep M Banús3, Carlos Cordon-Cardo4, Xavier Puig 1,2.

1BIOPAT, Grup Assistència, Barcelona, Spain; 2HISTOPAT Laboratoris, Barcelona, Spain; 3Institut Català d’Urologia i Nefrologia, ICUN; Barcelona, Spain; and 4Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA.

Bladder tumors have a high recurrence rate, so […]

2004-07-23T17:48:21+00:00

BRAF mutations in colorectal cancer are linked to loss of hMLH1 expression and proximal location, while independent of K-RAS activation

Anna Colomer1, Nadina Erill 1, August Vidal2, Ruth Román1, Montse Verdú2, Carlos Cordon-Cardo3, Xavier Puig 1,2.

1BIOPAT, Grup Assistència, Barcelona, Spain; 2HISTOPAT Laboratoris, Barcelona, Spain; 3Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York.

 The RAF gene family encodes RAS-regulated kinases that mediate cellular responses to growth signals. […]

2004-07-23T17:02:21+00:00

Hibridació in situ Fluorescent -FISH- en la detecció del carcinoma urotelial

N.Erill1, A.Colomer1, C Pubill1, N. Hannaoui3, R. Román1, M.Conangla2, JM. Banús3, C. Cordón1, X. Puig 1,2.

1BIOPAT, Grup Assistència; 2HISTOPAT Laboratoris, 3Institut Català d’Urologia i Nefrologia, ICUN; Barcelona.

El carcinoma urotelial de bufeta és un dels tumors malignes més freqüents al nostre entorn. S’associa a una elevada taxa de recurrència, al voltant d’un 80% dels casos, i […]

2004-06-23T17:46:45+00:00

Genetic and immunophenotype analyses of TP53 in bladder cancer: TP53 alterations are associated with tumor progression

Erill N1, Colomer A1, Verdú M2, Román R1, Condom E1, Hannaoui N3, Banús JM3, Cordón-Cardó C4, and Puig X 1,2.

1BIOPAT, Grup Assistència, Barcelona; 2HISTOPAT Laboratoris, Barcelona; 3ICUN, Barcelona; and 4Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York.

Altered p53 status is a frequent event in bladder cancer and reported to have prognostic significance. We […]

2004-02-09T22:14:36+00:00

Human papillomavirus and anogenital pathology

Román R1, Colomer A1, Erill N1, Calvo M3, Verdú M2, Cordon-Cardo C4, Puig X 1,2.

1BIOPAT, 2HISTOPAT Laboratoris and 3Statistics Dept. of the Universitat de Barcelona, Spain; and 4Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York.

Human papillomavirus (HPV) is the main etiologic factor for cervical cancer and its types are classified into low and […]

2003-07-23T17:55:01+00:00